CAS 1346452-25-2

Enfortumab vedotin-ejfv

CAS : 1346452-25-2

Enfortumab vedotin-ejfv

Degré de pureté : ≥95%

Ref: 54-BUP20308

Enfortumab vedotin-ejfv

CAS : 1346452-25-2

Enfortumab vedotin-ejfv (Padcev) is an ADC compound targeting Nectin-4 with anti-tumor activity, used in the study of urothelial carcinoma.

Degré de pureté : 100% (SEC-HPLC) - 96.33% (SEC-HPLC)

Couleur et forme : Liquid

Masse moléculaire : 143.9 kDa

Ref: TM-T78065

Enfortumab

CAS : 1346452-25-2

Anti-Human Nectin-4 Monoclonal Antibody

Ref: 3D-CLA1341